Chair, ACRE
Ashdown House
123 Victoria Street
London SW1E 6DE
The Agriculture and Environment Biotechnology Commission’s (AEBC’s) first report[1] evaluated the role of the Farm Scale Evaluations (FSEs) in the regulatory process. In its advice to Government on the FSE results[2], the Advisory Committee on Releases to the Environment (ACRE) noted that “the FSEs also have implications for agriculture in general, and may feed into a wider discussion concerning environmental impacts of agricultural practices”. ACRE has established a subgroup to examine these wider implications.
This open letter sets out some questions raised by the AEBC in its recent deliberations that we feel might be useful for ACRE, as part of the work of their subgroup, and for Government, in their consideration of the wider agricultural issues raised by the FSEs.
EC Directive 2001/18 obliges Member States to avoid “adverse effects” arising from the release of GM organisms into the environment. As part of the risk assessment for new GMO events in crops, the Directive requires the identification and evaluation of possible adverse effects of “the specific cultivation, management and harvesting techniques” associated with the particular GM crop. The assessment is made by comparison with an equivalent non-GM crop variety, used in a corresponding agricultural context, on a case-by-case basis for each GM variety.
Using this comparative approach, the results of the FSEs highlighted issues that have implications for both GM and non-GM crops and the management practices associated with them. For example:
These issues suggest a number of questions that the ACRE subgroup might want to consider:
o Are other possible comparative assessment systems available and what are their relative merits? Who would undertake them, and who should determine the criteria to use?
They also raise questions relevant to the Government’s considerations of the wider environmental impacts of agriculture:
· What systems can be used to consider the varying environmental impacts of different conventional crops and different management systems for the same crop?
· What objectives should be set for biodiversity, and the environmental impact of farming overall? How should other, socio-economic dimensions of sustainability be considered alongside these objectives? Is it practical to set targets for biodiversity, considering its complexity, or should future improvements in agricultural biodiversity be driven principally by the pragmatic introduction of practices known to be more favourable to wildlife?
· What stakeholder input would be needed to set these objectives in a robust way? Does the public debate on GM offer any lessons, positive or negative, for how this might be done?
· What new structures within Government will be needed to help meet these objectives?
· What further research might be needed to inform decisions? Should all crops and/or crop systems, past and future, be subject to assessment along the lines of the FSEs?
·
Although this
would require revision of the EU regulations, should other ways of regulating
GM and new non-GM crops, which would avoid or minimise some of the anomalies
of the current system, at least be considered (e.g. the Canadian model[5])?
This letter also goes to the Ministers to whom we report: Margaret Beckett, Secretary of State for Environment, Food and Rural Affairs; Patricia Hewitt, Secretary of State for Trade and Industry; Allan Wilson (Scottish Executive); Carwyn Jones (Welsh Assembly Government) and Angela Smith (Northern Ireland Office).
We hope that these points prove constructive and useful both for ACRE and for Government in their future consideration of the wider implications of the FSEs, and would be very happy to contribute further to ACRE’s work in this area.
Yours sincerely
Professor Malcolm Grant
AEBC Chairman
[1] Crops on Trial (September 2001). See http://www.aebc.gov.uk/aebc/reports/reports.shtml
[3] Freckleton et al (2004). Amelioration of biodiversity impacts of genetically modified crops: predicting transient versus long term effects. Proceedings of the Royal Society of London series B - Biological Sciences. 271(1536) pp 325-331. This is a paper that includes some modelling, using FSE type data, to illustrate that biodiversity benefits may be obtained by early spraying (rather than delaying spraying as in the FSEs).
[4] License conditions for Part B (non-commercial) releases of GMOs under Directive 2001/18, designed for small-scale plot work, may not necessarily reflect normal commercial practice.
[5] The Canadian regulatory system emphasises risk assessment on the basis of novel traits regardless of the technique or process used to generate the trait. “Plants which possess characteristics or traits sufficiently different from the same or similar species” require an assessment of risk. See http://www.inspection.gc.ca/english/sci/biotech/reg/bare.shtml.